Literature DB >> 27177398

Clinically relevant RHD-CE genotypes in patients with sickle cell disease and in African Brazilian donors.

Ane C Gaspardi1, Emília A Sippert1, Mayra Dorigan De Macedo1, Jordão Pellegrino1, Fernando F Costa1, Lilian Castilho1.   

Abstract

BACKGROUND: As a consequence of the homology and opposite orientation of RHD and RHCE, numerous gene rearrangements have occurred in Africans and resulted in altered RH alleles that predict partial antigens, contributing to the high rate of Rh alloimmunisation among patients with sickle cell disease (SCD). In this study, we characterised variant RH alleles encoding partial antigens and/or lacking high prevalence antigens in patients with SCD and in African Brazilian donors, in order to support antigen-matched blood for transfusion.
MATERIAL AND METHODS: RH genotypes were determined in 168 DNA samples from SCD patients and 280 DNA samples from African Brazilian donors. Laboratory developed tests, RHD BeadChip(TM), RHCE BeadChip(TM), cloning and sequencing were used to determine RHD-CE genotypes among patients and African Brazilian blood donors.
RESULTS: The distributions of RHD and RHCE alleles in donors and patients were similar. We found RHCE variant alleles inherited with altered RHD alleles in 25 out of 168 patients (15%) and in 22 out of 280 (7.8%) African Brazilian donors. The RHD and RHCE allele combinations found in the population studied were: RHD*DAR with RHCE*ceAR; RHD*weak D type 4.2.2 with RHCE*ceAR, RHD*weak D type 4.0 with RHCE*ceVS.01 and RHCE*ceVS.02; RHD*DIIIa with RHCE*ceVS.02. Thirteen patients and six donors had RHD-CE genotypes with homozygous or compound heterozygous alleles predicting partial antigens and/or lacking high prevalence antigens. Eleven patients were alloimmunised to Rh antigens. For six patients with RHD-CE genotypes predicting partial antigens, no donors with similar genotypes were found. DISCUSSION: Knowledge of the distribution and prevalence of RH alleles in patients with SCD and donors of African origin may be important for implementing a programme for RH genotype matching in SCD patients with RH variant alleles and clinically significant Rh antibodies.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27177398      PMCID: PMC5016305          DOI: 10.2450/2016.0275-15

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  21 in total

1.  RHD gene deletion occurred in the Rhesus box.

Authors:  F F Wagner; W A Flegel
Journal:  Blood       Date:  2000-06-15       Impact factor: 22.113

2.  Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach.

Authors:  R W Chiu; M F Murphy; C Fidler; B C Zee; J S Wainscoat; Y M Lo
Journal:  Clin Chem       Date:  2001-04       Impact factor: 8.327

3.  Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety.

Authors:  France Noizat-Pirenne; Ketty Lee; Pierre-Yves Le Pennec; Philippe Simon; Philippe Kazup; Dora Bachir; Anne-Marie Rouzaud; Michele Roussel; Geneviève Juszczak; Cècile Ménanteau; Philippe Rouger; Rami Kotb; Jean-Pierre Cartron; Hélène Ansart-Pirenne
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

Review 4.  Relevance of RH variants in transfusion of sickle cell patients.

Authors:  F Noizat-Pirenne; C Tournamille
Journal:  Transfus Clin Biol       Date:  2011-10-22       Impact factor: 1.406

5.  Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy.

Authors:  D R Ambruso; J H Githens; R Alcorn; D J Dixon; L J Brown; W M Vaughn; T Hays
Journal:  Transfusion       Date:  1987 Jan-Feb       Impact factor: 3.157

6.  How I manage donors and patients with a weak D phenotype.

Authors:  Willy A Flegel
Journal:  Curr Opin Hematol       Date:  2006-11       Impact factor: 3.284

7.  RHCE*ceCF encodes partial c and partial e but not CELO, an antigen antithetical to Crawford.

Authors:  Christine Halter Hipsky; Christine Lomas-Francis; Akiko Fuchisawa; Marion E Reid; Marilyn Moulds; Joann Christensen; Pam Nickle; Sunitha Vege; Connie Westhoff
Journal:  Transfusion       Date:  2011-01       Impact factor: 3.157

8.  Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.

Authors:  Oswaldo Castro; S Gerald Sandler; Patricia Houston-Yu; Sohail Rana
Journal:  Transfusion       Date:  2002-06       Impact factor: 3.157

9.  Anti-D auto-immunization in a patient with weak D type 4.0.

Authors:  M Ouchari; T Chakroun; S Abdelkefi; H Romdhane; B Houissa; S Jemni Yacoub
Journal:  Transfus Clin Biol       Date:  2013-12-22       Impact factor: 1.406

10.  High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.

Authors:  Stella T Chou; Tannoa Jackson; Sunitha Vege; Kim Smith-Whitley; David F Friedman; Connie M Westhoff
Journal:  Blood       Date:  2013-05-30       Impact factor: 22.113

View more
  7 in total

1.  Diversity of RH and transfusion support in Brazilian sickle cell disease patients with unexplained Rh antibodies.

Authors:  Carla L Dinardo; Shannon Kelly; Marcia R Dezan; Ingrid H Ribeiro; Shirley L Castilho; Luciana C Schimidt; Maria do C Valgueiro; Liliana R Preiss; Brian Custer; Ester C Sabino; Connie M Westhoff
Journal:  Transfusion       Date:  2019-08-13       Impact factor: 3.157

2.  Rh antibodies as a result of altered Rh epitopes on transfused red cells: a case series of seven Brazilian patients.

Authors:  Mayra D Macedo; Maria R Miranda; Tamires D Santos; Ianca Leal; Lilian Castilho
Journal:  Blood Transfus       Date:  2020-10-09       Impact factor: 3.443

Review 3.  Transfusion Support of Minority Patients: Extended Antigen Donor Typing and Recruitment of Minority Blood Donors.

Authors:  Jenna Khan; Meghan Delaney
Journal:  Transfus Med Hemother       Date:  2018-07-19       Impact factor: 3.747

Review 4.  Genotyping in Sickle Cell Disease Patients: The French Strategy.

Authors:  Aline Floch; Christophe Tournamille; Btissam Chami; France Pirenne
Journal:  Transfus Med Hemother       Date:  2018-07-06       Impact factor: 3.747

Review 5.  Optimized Antigen-Matched in Sickle Cell Disease Patients: Chances and Challenges in Molecular Times - the Brazilian Way.

Authors:  Lilian Castilho; Carla Luana Dinardo
Journal:  Transfus Med Hemother       Date:  2018-07-06       Impact factor: 3.747

6.  A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data.

Authors:  Ti-Cheng Chang; Kelly M Haupfear; Jing Yu; Evadnie Rampersaud; Vivien A Sheehan; Jonathan M Flanagan; Jane S Hankins; Mitchell J Weiss; Gang Wu; Sunitha Vege; Connie M Westhoff; Stella T Chou; Yan Zheng
Journal:  Blood Adv       Date:  2020-09-22

Review 7.  Transfusion and Cellular Therapy in Pediatric Sickle Cell Disease.

Authors:  Yan Zheng; Stella T Chou
Journal:  Clin Lab Med       Date:  2020-12-24       Impact factor: 1.935

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.